Magnesium in disease prevention and overall health

Advances in Nutrition

Volumn 4, Issue 3, 2013, Pages

  Volpe, Stella Lucia ^a  

^a DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM;

AGE; ALZHEIMER DISEASE; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIETARY REFERENCE INTAKE; FEMALE; FOOD; HUMAN; HYPERTENSION; MAGNESIUM DEFICIENCY; MALE; MIGRAINE DISORDERS; PHYSIOLOGY; STROKE; CEREBROVASCULAR ACCIDENT; MIGRAINE; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

AGE FACTORS; ALZHEIMER DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; FOOD; HUMANS; HYPERTENSION; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; MIGRAINE DISORDERS; RECOMMENDED DIETARY ALLOWANCES; STROKE;

EID: 84884824793     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.112.003483     Document Type: Article

References (49)

1. Elin RJ. Magnesium: the fifth but forgotten electrolyte. Am J Clin Pathol. 1994;102:616-22.
2. Takaya J, Higashino H, Kobayashi Y. Intracellular magnesium and insulin resistance. Magnes Res. 2004;17:126-36.
3. Newhouse IJ, Finstad EW. The effects of magnesium supplementation on exercise performance. Clin J Sport Med. 2000;10:195-200.
4. Bohl CH, Volpe SL. Magnesium and exercise. Crit Rev Food Sci Nutr. 2002;42:533-63.
5. Shils ME. Magnesium. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern nutrition in health and disease. 9th ed. Baltimore, MD: Lippincott Williams & Wilkins; 1999. p. 169-92.
6. Chubanov V, Gudermann T, Schlingmann KP. Essential role for TRPM6 in epithelial magnesium transport and body magnesium homeostasis. Pflugers Arch. 2005;451:228-34.
7. Paolisso G, Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens. 1997; 10:346-55.
8. Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L, Pineo A, Busardo' A, Paolisso G. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med. 2003;24: 39-52.
9. He K, Liu K, Daviglus ML, Morris SJ, Loria CM, Van Horn L, Jacobs DR Jr, Savage PJ. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation. 2006;113:1675-82.
10. Murakami K, Okubo H, Sasaki S. Effect of dietary factors on incidence of type 2 diabetes: a systematic review of cohort studies. J Nutr Sci Vitaminol (Tokyo). 2005;51:292-310.
11. Guerrero-Romero F, Rodriguez-Moran M. Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values. J Diabetes Complications. 2000;14:272-6.
12. Gropper SS, Smith JL, Groff JL. Magnesium. Advanced nutrition and human metabolism. 4th ed. Belmont, CA: Thomson and Wadsworth; 2005.
13. Soltani N, Keshavarz M, Minaii B, Mirershadi F, Asl SZ, Dehpour AR. Effects of administration of oral magnesium on plasma glucose and pathological changes in the aorta and pancreas of diabetic rats. Clin Exp Pharmacol Physiol. 2005;32:604-10.
14. McCarty MF. Magnesium may mediate the favorable impact of whole grains on insulin sensitivity by acting as a mild calcium antagonist. Med Hypotheses. 2005;64:619-27.
15. Lopez-Ridaura R, Willett WC, Rimm EB, Liu S, Stampfer MJ, Manson JE, Hu FB. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care. 2004;27:134-40.
16. Guerrero-Romero F, Rodríguez-Morán M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol. 2002;39:209-13.
17. Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU, Gok M, Caglar K, Oguz Y, Yenicesu M, et al. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients. Am J Nephrol. 2012;36:228-37.
18. Kupetsky-Rincon EA, Uitto J. Magnesium: novel applications in cardiovascular disease. A review of the literature. Ann Nutr Metab. 2012;61: 102-10.
19. Kupetsky-Rincon EA, Li Q, Uitto J. Magnesium reduces carotid intimamedia thickness in a mouse model of pseudoxanthoma elasticum: a novel treatment biomarker. Clin Transl Sci. 2012;5:259-64.
20. Reed BN, Zhang S, Marron JS, Montague D. Comparison of intravenous and oral magnesium replacement in hospitalized patients with cardiovascular disease. Am J Health Syst Pharm. 2012;69:1212-7.
21. Abbasi IU, Salim-ul-Haque, Kausar MW, Karira KA, Zubaris NA. Correlation of divalent cat ions (Ca++, Mg++) and serum renin in patients of essential hypertension. J Pak Med Assoc. 2012;62:134-8.
22. Barbagallo M, Belvedere M, Di Bella G, Dominguez LJ. Altered ionized magnesium levels in mild-to-moderate Alzheimer's disease. Magnes Res. 2011;24:S115-21.
23. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: National Academies Press; 1997.
24. Subramanian NK, White PJ, Broadley MR, Ramsay G. The threedimensional distribution of minerals in potato tubers. Ann Bot. 2011; 107:681-91.
25. Freedman MR, Keast DR. White potatoes, including French fries, contribute shortfall nutrients to children's and adolescents' diets. Nutr Res. 2011;31:270-7.
26. U.S. Department of Agriculture, Agricultural Research Service. 2011. USDA National Nutrient Database for Standard Reference, Release 24. Nutrient Data Laboratory Home Page, http://www.ars.usda.gov/ba/bhnrc/ndl, retrieved September 16, 2012.
27. Nielsen FH. Magnesium, inflammation, and obesity in chronic disease. Nutr Rev. 2010;68:333-40.
28. Office of Dietary Supplements. Dietary Supplement Fact Sheet: Magnesium. http://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/, retrieved September 16, 2012
29. Freedman MR, Keast DR. Potatoes, including French fries, contribute key nutrients to diets of U. adults: NHANES 2003-2006. J Nutr Ther. 2012;1:1-11.
30. Arnaud MJ. Update on the assessment of magnesium status. Br J Nutr. 2008;99(SUPPL 3):S24-36.
31. World Health Organization. Headache disorders. Fact Sheet #277. http://www.who.int/mediacentre/factsheets/fs277/en/, retrieved September 16, 2012.
32. Mauskop A. Nonmedication, alternative, and complementary treatments for migraine. Continuum (Minneap Minn). 2012;18:796-806.
33. Pringsheim T, DavenportW, Mackie G,Worthington I, Aubé M, Christie SN, Gladstone J, Becker WJ; Canadian Headache Society Prophylactic Guidelines Development Group. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci. 2012; 39(2, SUPPL 2)S1-59.
34. Tarighat Esfanjani A, Mahdavi R, Ebrahimi Mameghani M, Talebi M, Nikniaz Z, Safaiyan A. The effects of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation in migraine prophylaxis. Biol Trace Elem Res. 2012;150:42-8.
35. Centers for Disease Control and Prevention. Fast Stats. http://www.cdc.gov/nchs/fastats/lcod.htm/, retrieved September 16, 2012.
36. Ozawa M, Ninomiya T, Ohara T, Hirakawa Y, Doi Y, Hata J, Uchida K, Shirota T, Kitazono T, Kiyohara Y. Self-reported dietary intake of potassium, calcium, and magnesium and risk of dementia in the Japanese: The Hisayama study. J Am Geriatr Soc. 2012;60:1515-20.
37. Larsson SC, Orsini N, Wolk A. Dietary magnesium intake and risk of stroke: a meta-analysis of prospective studies. Am J Clin Nutr. 2012; 95:362-6.
38. Dickinson HO, Nicolson DJ, Campbell F, Cook JV, Beyer FR, Ford GA, Mason J. Magnesium supplementation for the management of essential hypertension in adults. Cochrane Database Syst Rev. 2006; (3): CD004640.
39. Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr. 2012;66:411-8.
40. Bo S, Pisu E. Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Curr Opin Lipidol. 2008;19: 50-6.
41. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol. 1995;48: 927-40.
42. Altura BT, Brust M, Bloom S, Barbour RL, Stempak JG, Altura BM. Magnesium dietary intake modulates blood lipid levels and atherogenesis. Proc Natl Acad Sci U S A. 1990;87:1840-4.
43. Orimo H, Ouchi Y. The role of calcium and magnesium in the development of atherosclerosis. Experimental and clinical evidence. Ann N Y Acad Sci. 1990;598:444-57.
44. Song Y, Manson JE, Cook NR, Albert CM, Buring JE, Liu S. Dietary magnesium intake and risk of cardiovascular disease among women. Am J Cardiol. 2005;96:1135-41.
45. Chakraborti S, Chakraborti T, Mandal M, Mandal A, Das S, Ghosh S. Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem. 2002;238:163-79.
46. Houston M. The role of magnesium in hypertension and cardiovascular disease. J Clin Hypertens (Greenwich). 2011;13:843-7.
47. Guerrero-Romero F, Tamez-Perez HE, González-González G, Salinas-Martínez AM, Montes-Villarreal J, Treviño-Ortiz JH, Rodríguez-Morán M. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebocontrolled randomized trial. Diabetes Metab. 2004;30:253-8.
48. Mooren FC, Krüger K, Völker K, Golf SW, Wadepuhl M, Kraus A. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial. Diabetes Obes Metab. 2011;13:281-4.
49. Barbagallo M, Dominguez LJ, Galioto A, Pineo A, Belvedere M. Oral magnesium supplementation improves vascular function in elderly diabetic patients. Magnes Res. 2010;23:131-7.